6-BROMO-2-METHOXYQUINAZOLINE, 95%, 1g

(S)-4-Ethynyl-2,2-dimethyl-1,3-dioxolane, 95%, 100mg

n-[4-(2-chloroacetyl)phenyl]methanesulfonamide, 98%, 1g

Fmoc-D-Asp(OtBu)-OH, 98%, 10g

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-methoxyphenyl)propanoic acid, 97%, 5g

5-Bromo-1,2-dimethyl-1H-imidazole, 95.0%, 25g

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)propan-1-amine, 95%, 250mg

Bottiglia a bocca stretta con giunto in vetro smerigliato Vetro trasparente, 1000 ml, Bottiglia a bocca stretta in vetro sodo-calcico, trasparente. acc. aDIN12036, ISO4796. Con tappo in vetro NS 29/32, volume 1000 ml, 1 pezzo

5-Bromo-3-methyl-1H-indole, 95.0%, 1g

6-Bromo-7-methyl-2,3-dihydro-1H-inden-1-one, 95.0%, 100mg

tert-butyl 3-{[3-(diethylamino)propyl]amino}-2-methylpropanoate, 95.0%, 10g

Glicole propilenico fenil etere, min 99%, per sintesi, 1L, confezione in plastica.

1-CHLORO-6-FLUOROISOQUINOLINE, 95.0%, 25g